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Abstract
Objective—Serum concentrations of solu-
ble (s) L-selectin (CD62L) were measured
in patients with primary Sjögren’s syn-
drome (SS) to relate these concentrations
to clinical and immunological features of
SS.
Methods—The study included 40 consecu-
tive patients (38 women and twomen) with
a mean age of 61 years (range 24–78) who
fulfilled four or more of the preliminary
diagnostic criteria for SS proposed by the
European Community Study Group in
1993, and 33 healthy blood donors from the
hospital blood bank. A sandwich enzyme
linked immunosorbent assay (ELISA) was
used to detect the soluble form of human
sL-selectin (CD62L).
Results—The mean (SEM) values of sL-
selectin (CD62L) were 861 (66) µg/ml for
patients with SS and 986 (180) µg/ml for
healthy blood donors, but there was no
significant diVerence. In patients with
primary SS, serum sL-selectin (CD62L)
concentrations were significantly higher
in patients with Raynaud’s phenomenon
(1275 (112) µg/ml versus 789 (69) µg/ml,
p=0.007), autoimmune thyroiditis (1162
(113) µg/ml versus 787 (69) µg/ml, p=0.02)
and rheumatoid factor (993 (95) µg/ml
versus 684 (70) µg/ml, p=0.01) when com-
pared with patients without these fea-
tures.
Conclusion—The presence of Raynaud’s
phenomenon, autoimmune thyroiditis
and rheumatoid factor is associated with
higher concentrations of circulating sL-
selectin (CD62L) in the sera of patients
with primary SS.
(Ann Rheum Dis 2000;59:297–299)
Sjögren’s syndrome (SS) is an autoimmune
disease that mainly aVects exocrine glands and
that usually presents as a persistent dryness of
the mouth and the eyes resulting from
functional impairment of the salivary and
lacrimal glands.1 The spectrum of the disease
extends from an organ specific autoimmune
disease (autoimmune exocrinopathy)2 to a sys-
temic process (musculoskeletal, pulmonary,
gastric, haematological, vascular, dermatologi-
cal, renal and nervous system involvement).3 In
the absence of an associated systemic autoim-
mune disease, patients with this condition are
classified as having “primary” SS. Because of
this heterogeneity, attempts have been made to
identify subsets of patients that would permit
more reliable prediction of the course of
primary SS in the aVected people.4 5
Adhesion molecules regulate cell-cell and
cell-matrix interactions and determine lym-
phocyte homing to diVerent lymphoid organs
and sites of inflammation.6 Such molecules
have been classified into several families, of
which the selectins are one.7 L-selectin
(CD62L) mediates leucocyte rolling on vascu-
lar endothelium at sites of inflammation and
the recirculation of lymphocytes through the
binding to high endothelial venules of periph-
eral lymph nodes.7 8 Indeed, leucocytes from
mice lacking L-selectin (CD62L) have defi-
ciencies in both functions.9 L-selectin
(CD62L) is constitutively expressed on the
surface of most leucocytes, including lym-
phocytes, neutrophils, monocytes, eosinophils,
haematopoietic progenitor cells, and immature
thymocytes. L-selectin (CD62L) is cleaved
enzymatically from the leucocyte surface mem-
brane after cell activation and released into the
bloodstream.10 Soluble (s) L-selectin (CD62L)
is functionally active and is present at high
concentrations in human serum.11
Primary SS is associated with lymphocytic
infiltration in salivary, lacrimal and other
exocrine glands. The mechanism of lym-
phocytic infiltration is not known. The interac-
tion between adhesion molecules, expressed on
the surface of lymphocytes, and their specific
ligands, expressed on endothelial cells and
subsequently other cells in exocrine glands,
may be the main mechanism for lymphocyte
infiltration into sites of inflammation in this
disease, contributing to the retention of
lymphocytes in target organs of the autoim-
mune attack. No information is yet available on
the physiological and clinical significance of the
circulating shed forms of adhesion molecules
in primary SS. This study was undertaken to
determine sL-selectin (CD62L) concentra-
tions in patients with primary SS and to evalu-
ate the relation with the clinical and immuno-
logical features of SS.
Methods
PATIENTS
We included 40 consecutive patients (38
women and two men) with a mean age at onset
of SS of 51 years (range 24–78). All patients
fulfilled four or more of the preliminary
diagnostic criteria for SS proposed by the
European Community Study Group in 1993.12
All patients underwent a complete history and
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physical examination, and diagnostic tests for
SS were applied according to the recommenda-
tions of the European Community Study
Group.12 Ten (25%) patients had disease
limited to the exocrine glands, and the remain-
ing 30 (75%) had one or more of the following
extraglandular manifestations: arthralgia
and/or arthritis, Raynaud’s phenomenon, inter-
stitial pneumonitis (evidence of interstitial
fibrosis on chest radiography and/or in the high
resolution computed tomography), cutaneous
vasculitis (demonstrated by cutaneous purpura
and skin biopsy), autoimmune thyroiditis
(positive autoantibodies and/or altered thry-
roid function), peripheral neuropathy (demon-
strated by the clinical picture and nerve
conduction tests) and liver involvement (al-
tered liver function tests and/or liver biopsy).
The serum concentrations of sL-selectin
(CD62L) of these patients were compared with
those of the 33 healthy blood donors from our
hospital blood bank.
LABORATORY STUDIES
A sandwich enzyme linked immunosorbent
assay (ELISA) to detect the soluble form of
human L-selectin (CD62L) was performed as
previously described, with slight
modifications.11 Anti-L-selectin (CD62L)
mAb LAM1–101 diluted to 3 µg/ml was used
as the capture antibody. The presence of
sL-selectin was shown with biotinylated anti-
LAM1–116 monoclonal antibody at 3 µg/ml
and avidin-horseradish peroxidase, with
O-phenylene-diamine (0.125% wt/vol, Sigma,
St Louis, MO) as substrate. Human serum
samples were run in triplicate and diluted at
1/40 to obtain a measurement in the linear
range of our assay. Absorbances at 450 nm
were measured using an MRX Microplate
ELISA reader (Dynatech, Denkendorf, Ger-
many). The concentration of sL-selectin was
determined by using a standard curve con-
structed for each ELISA plate with recom-
binant L-selectin (CD62L) and results are
expressed as µg/ml.
Immunological tests included determination
of antinuclear antibodies (ANA) by indirect
immunofluorescence using mouse liver as sub-
strate, antibodies to double stranded DNA by
Farr’s technique, precipitating antibodies to
the extractable nuclear antigens Ro/SS-A and
La/SS-B by counterimmunoelectrophoresis
and rheumatoid factor (RF) by latex fixation
and Waaler-Rose tests. Complement factors
(C3 and C4) were estimated by nephelometry
(Behring BNA nephelometer). Serum cryo-
globulinaemia was measured after centrifuga-
tion. Centrifugated serum was incubated at
4°C for seven days and examined for cryopre-
cipitation.
STATISTICAL ANALYSIS
We used conventional ÷2 and Fisher’s exact test
to analyse qualitative diVerences, Student’s test
for the comparison of means in large samples of
similar variance, and the non-parametric
Mann-Whitney U test for small samples. A
value of p < 0.05 was taken to indicate statisti-
cal significance. This statistical analysis was
performed by means of the SPSS program
using the information stored in the database
program.
Results
We measured the serum concentrations of
sL-selectin (CD62L) in 40 patients with
primary SS and in 33 healthy blood donors.
The mean (SEM) values of sL-selectin
(CD62L) were 861 (66) µg/ml for patients with
SS and 986 (180) µg/ml for healthy blood
donors, but there was no significant diVerence
(fig 1).
The most common extraglandular manifes-
tations in our patients with primary SS were
articular involvement in 20 (50%) patients,
liver involvement in nine (23%), peripheral
neuropathy in eight (20%), cutaneous vasculi-
tis in eight (20%), autoimmune thyroiditis in
eight (20%), Raynaud’s phenomenon in six
(15%) and interstitial pneumonitis in two
(5%). Serum sL-selectin (CD62L) concentra-
tions were significantly higher in patients with
Raynaud’s phenomenon (1275 (112) µg/ml v
789 (69) µg/ml, p=0.007) and autoimmune
thyroiditis (1162 (113) µg/ml v 787 + 69 µg/ml,
p=0.02) when compared with patients without
these manifestations (table 1).
The most frequent immunological features
were: ANA in 25 (63%) patients, RF in 23
(58%), anti-Ro/SS-A antibodies in 13 (33%),
Figure 1 Serum concentrations of soluble L-selectin in patients with Sjögren’s syndrome
and controls. Box plots indicate the overall range (error bars), 25–75% range (boxes) and
median value (horizontal lines).
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Table 1 Mean serum sL-selectin (CD62L) in SS patients
grouped according to the presence or absence of
extraglandular and immunological features
sL-selectin (mean (SEM))
pPresent Absent
Extraglandular manifestation
Articular involvement 766 (89) 958 (96) NS
Raynaud’s phenomenon 1275 (112) 789 (69) 0.007
Cutaneous vasculitis 936 (198) 843 (68) NS
Liver involvement 839 (162) 868 (73) NS
Autoimmune thyroiditis 1162 (113) 787 (72) 0.02
Interstitial pneumonitis 1286 (247) 839 (67) NS
Peripheral neuropathy 863 (204) 861 (67) NS
Immunological manifestation
ANA 817 (76) 936 (124) NS
Anti-Ro/SS-A 891 (126) 838 (81) NS
Anti-La/SS-B 952 (158) 841 (75) NS
RF 993 (95) 684 (70) 0.01
Cryoglobulins 1016 (236) 848 (75) NS
Hypocomplementaemia 1055 (286) 768 (71) NS
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cryoglobulinaemia in 6 of 34 (18%), hypocom-
plementaemia in 5 of 30 (17%) and anti-La/
SS-B antibodies in five (13%) patients. No
patient had a positive titre of anti-dsDNA or
anti-Sm antibodies. Serum sL-selectin
(CD62L) concentrations were significantly
higher in patients with RF compared with
those without RF (993 (95) µg/ml compared
with 684 (70) µg/ml, p=0.01) (table 1).
Discussion
Investigation into adhesion molecule patho-
physiology in primary SS is scarce and has
focused on characterising adhesion molecule
expression in salivary gland biopsy
specimens.13 L-selectin was found to be ex-
pressed by 18% of the infiltrating cells in labial
salivary glands from patients with primary SS,13
which is considerably less than in the periph-
eral blood, and the comparatively reduced
number of CD62 L positive lymphocytes might
be attributable to shedding of the L-selectin
(CD62L) after cell activation.
In our study, we found increased concentra-
tions of circulating sL-selectin (CD62L) in
patients with primary SS that present with
some extraglandular manifestations. Firstly,
patients with primary SS and Raynaud’s
phenomenon showed higher circulating con-
centrations of sL-selectin (CD62L). In pri-
mary SS, Raynaud’s phenomenon is not
constantly observed, and it could result from a
specific immunological aggression. The mol-
ecule analysed in our study promotes the
attachment of diverse leucocytes to endothe-
lium, and thereby together regulates the local
traYc of neutrophils, monocytes, and lym-
phocytes. L-selectin is shed after cell activation,
and raised sL-selectin (CD62L) concentra-
tions may reflect a higher grade of activation of
the leucocytes occurring in this subset of
patients with primary SS and associated
Raynaud’s phenomenon.
A second subset of patients with primary SS,
those with autoimmune thyroiditis, showed
higher values of circulating sL-selectin
(CD62L) in their sera. Autoimmune thyroiditis
is an organ specific, autoimmune destruction
of the thyroid gland mediated by T lym-
phocytes, with anti-thyroglobulin and anti-
microsomal antibody formation, frequently
associated to SS.14 Stimulation of thyroid
epithelial cells in vitro with tumour necrosis
factor á or interferon ã induced expression of
ICAM-1.15 ICAM-1 and LFA-3 expression has
been identified on thyroid cells in autoimmune
thyroiditis, and it has been suggested that these
molecules have functional importance in lead-
ing to the adherence of T cells to this target
organ.16 Adhesion molecules might participate
in the pathophysiology of autoimmune thy-
roiditis in primary SS patients.
The presence of Raynaud’s phenomenon,
autoimmune thyroiditis and rheumatoid factor
is associated with higher concentrations of cir-
culating sL-selectin (CD62L) in the sera of
patients with primary SS. Measurement of
sL-selectin (CD62L) in primary SS may also
provide guidance in the selection of clinical
subsets of patients in which pharmacological
blockade of adhesion molecules should be
attempted, to interfere with leucocyte migra-
tion and function.
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